Literature DB >> 18229680

Population sequencing using short reads: HIV as a case study.

Vladimir Jojic1, Tomer Hertz, Nebojsa Jojic.   

Abstract

Despite many drawbacks, traditional sequencing technologies have proven to be invaluable in modern medical research, even when the targeted genomes are highly variable. While it is often known in such cases that multiple slightly different sequences are present in the analyzed sample in concentrations that vary dramatically, the traditional techniques typically allow only the most dominant strain to be extracted from a single chromatogram. These limitations made some research directions rather difficult to pursue. For example, the analysis of HIV evolution (including the emergence of drug resistance) in a single patient is expected to benefit from a comprehensive catalog of the patient's HIV population. In this paper, we show how the new generation of sequencing technologies, based on high throughput of short reads, can be used to link site variants and reconstruct multiple full strains of the targeted gene, including those of low concentration in the sample. Our algorithm is based on a generative model of the sequencing process, and uses a tailored probabilistic inference and learning procedure to fit the model to the obtained reads.

Entities:  

Mesh:

Year:  2008        PMID: 18229680

Source DB:  PubMed          Journal:  Pac Symp Biocomput        ISSN: 2335-6928


  10 in total

1.  QuRe: software for viral quasispecies reconstruction from next-generation sequencing data.

Authors:  Mattia C F Prosperi; Marco Salemi
Journal:  Bioinformatics       Date:  2011-11-15       Impact factor: 6.937

2.  Analysis of HIV-1 expression level and sense of transcription by high-throughput sequencing of the infected cell.

Authors:  Gregory Lefebvre; Sébastien Desfarges; Frédéric Uyttebroeck; Miguel Muñoz; Niko Beerenwinkel; Jacques Rougemont; Amalio Telenti; Angela Ciuffi
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

3.  Read length versus depth of coverage for viral quasispecies reconstruction.

Authors:  Osvaldo Zagordi; Martin Däumer; Christian Beisel; Niko Beerenwinkel
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

4.  Challenges and opportunities in estimating viral genetic diversity from next-generation sequencing data.

Authors:  Niko Beerenwinkel; Huldrych F Günthard; Volker Roth; Karin J Metzner
Journal:  Front Microbiol       Date:  2012-09-11       Impact factor: 5.640

5.  Combinatorial analysis and algorithms for quasispecies reconstruction using next-generation sequencing.

Authors:  Mattia C F Prosperi; Luciano Prosperi; Alessandro Bruselles; Isabella Abbate; Gabriella Rozera; Donatella Vincenti; Maria Carmela Solmone; Maria Rosaria Capobianchi; Giovanni Ulivi
Journal:  BMC Bioinformatics       Date:  2011-01-05       Impact factor: 3.169

6.  ShoRAH: estimating the genetic diversity of a mixed sample from next-generation sequencing data.

Authors:  Osvaldo Zagordi; Arnab Bhattacharya; Nicholas Eriksson; Niko Beerenwinkel
Journal:  BMC Bioinformatics       Date:  2011-04-26       Impact factor: 3.307

7.  Population-Sequencing as a Biomarker for Sample Characterization.

Authors:  John P Jakupciak
Journal:  J Biomark       Date:  2013-12-08

8.  A penalized regression approach to haplotype reconstruction of viral populations arising in early HIV/SIV infection.

Authors:  Sivan Leviyang; Igor Griva; Sergio Ita; Welkin E Johnson
Journal:  Bioinformatics       Date:  2017-08-15       Impact factor: 6.937

9.  Empirical validation of viral quasispecies assembly algorithms: state-of-the-art and challenges.

Authors:  Mattia C F Prosperi; Li Yin; David J Nolan; Amanda D Lowe; Maureen M Goodenow; Marco Salemi
Journal:  Sci Rep       Date:  2013-10-03       Impact factor: 4.379

10.  Viral quasispecies inference from 454 pyrosequencing.

Authors:  Wan-Ting Poh; Eryu Xia; Kwanrutai Chin-Inmanu; Lai-Ping Wong; Anthony Youzhi Cheng; Prida Malasit; Prapat Suriyaphol; Yik-Ying Teo; Rick Twee-Hee Ong
Journal:  BMC Bioinformatics       Date:  2013-12-05       Impact factor: 3.169

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.